Grifols (GIKLY) Enterprise Value Growth (5y) (2015 - 2025)

Grifols (GIKLY) Enterprise Value Growth (5y) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -22.73%
Dec 31, 2024 -24.10%
Dec 31, 2023 2.21%
Dec 31, 2022 10.46%
Dec 31, 2021 -25.85%
Dec 31, 2020 24.46%
Sep 30, 2020 23.14%
Mar 31, 2020 33.09%
Dec 31, 2019 23.14%
Dec 31, 2018 7.04%
Sep 30, 2018 -2.51%
Jun 30, 2018 -4.61%
Mar 31, 2018 24.83%
Dec 31, 2017 -11.51%
Jun 30, 2017 -14.46%
Mar 31, 2017 76.45%
Dec 31, 2016 -15.00%
Sep 30, 2016 -33.76%
Jun 30, 2016 -2.26%
Mar 31, 2016 -35.21%